Resuscitating the Microcirculation in Sepsis: The Central Role of Nitric Oxide, Emerging Concepts for Novel Therapies, and Challenges for Clinical Trials
Open Access
- 17 April 2008
- journal article
- review article
- Published by Wiley in Academic Emergency Medicine
- Vol. 15 (5) , 399-413
- https://doi.org/10.1111/j.1553-2712.2008.00109.x
Abstract
Microcirculatory dysfunction is a critical element of the pathogenesis of severe sepsis and septic shock. In this Bench‐to‐Bedside review, we present: 1) the central role of the microcirculation in the pathophysiology of sepsis; 2) new translational research techniques of in vivo video microscopy for assessment of microcirculatory flow in human subjects; 3) clinical investigations that reported associations between microcirculatory dysfunction and outcome in septic patients; 4) the potential role of novel agents to “rescue” the microcirculation in sepsis; 5) current challenges facing this emerging field of clinical investigation; and 6) a framework for the design of future clinical trials aimed to determine the impact of novel agents on microcirculatory flow and organ failure in patients with sepsis. We specifically focus this review on the central role and vital importance of the nitric oxide (NO) molecule in maintaining microcirculatory homeostasis and patency, especially when the microcirculation sustains an insult (as with sepsis). We also present the scientific rationale for clinical trials of exogenous NO administration to treat microcirculatory dysfunction and augment microcirculatory blood flow in early sepsis therapy.Keywords
This publication has 155 references indexed in Scilit:
- Impairments in microvascular reactivity are related to organ failure in human sepsisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- The Association of Sepsis Syndrome and Organ Dysfunction With Mortality in Emergency Department Patients With Suspected InfectionAnnals of Emergency Medicine, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortalityThe Journal of Experimental Medicine, 2006
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- Bench to Bedside: The Role of Mitochondrial Medicine in the Pathogenesis and Treatment of Cellular InjuryAcademic Emergency Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic ratsCritical Care Medicine, 2000
- Effects of the nitric oxide synthase inhibitors NG-nitrol-L-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemiaJournal of Hepatology, 1998
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996